Article Text
Editorial
Ivabradine is cost-effective in the treatment of chronic heart failure
Statistics from Altmetric.com
Footnotes
-
Contributors SM and RH both wrote the first draft of the editorial. Both authors contributed significantly to the final draft.
-
Competing interests None.
-
Provenance and peer review Commissioned; internally peer reviewed.